ATE364370T1 - Kosmetische und dermatologische zusammensetzung enthaltend ein n-acylaminoamid-derivat und einen metalloproteinase-inhibitor - Google Patents

Kosmetische und dermatologische zusammensetzung enthaltend ein n-acylaminoamid-derivat und einen metalloproteinase-inhibitor

Info

Publication number
ATE364370T1
ATE364370T1 AT02291597T AT02291597T ATE364370T1 AT E364370 T1 ATE364370 T1 AT E364370T1 AT 02291597 T AT02291597 T AT 02291597T AT 02291597 T AT02291597 T AT 02291597T AT E364370 T1 ATE364370 T1 AT E364370T1
Authority
AT
Austria
Prior art keywords
cosmetic
dermatological composition
composition containing
metalloproteinase inhibitor
acylaminoamide
Prior art date
Application number
AT02291597T
Other languages
English (en)
Inventor
Lionel Breton
Yann Mahe
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE364370T1 publication Critical patent/ATE364370T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02291597T 2001-06-26 2002-06-26 Kosmetische und dermatologische zusammensetzung enthaltend ein n-acylaminoamid-derivat und einen metalloproteinase-inhibitor ATE364370T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108433A FR2826266B1 (fr) 2001-06-26 2001-06-26 Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles

Publications (1)

Publication Number Publication Date
ATE364370T1 true ATE364370T1 (de) 2007-07-15

Family

ID=8864798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02291597T ATE364370T1 (de) 2001-06-26 2002-06-26 Kosmetische und dermatologische zusammensetzung enthaltend ein n-acylaminoamid-derivat und einen metalloproteinase-inhibitor

Country Status (8)

Country Link
US (2) US6884425B2 (de)
EP (1) EP1275372B1 (de)
JP (2) JP2003048809A (de)
AT (1) ATE364370T1 (de)
CA (1) CA2391585A1 (de)
DE (1) DE60220594T2 (de)
ES (1) ES2286215T3 (de)
FR (1) FR2826266B1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826267B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent myorelaxant
FR2826262B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un compose agissant sur la chute ou la repousse des cheveux
JP2008520588A (ja) * 2004-11-18 2008-06-19 ビオファーマコペ デジン アンテルナショナル インク． 植物抽出物およびその皮膚科使用法
WO2006053790A1 (en) * 2004-11-22 2006-05-26 L'oreal Use of compounds of the n-acylaminoamide family as soothing or calming agents
FR2878155A1 (fr) * 2004-11-22 2006-05-26 Oreal Protection de la peau contre les alterations liees a un dysfonctionnement des mecanismes physiologiques d'apoptose
FR2878156A1 (fr) * 2004-11-22 2006-05-26 Oreal Utilisation des composes de la famille des n-acylamino-amides comme agents apaisants
WO2006053789A1 (en) * 2004-11-22 2006-05-26 L'oreal Protection of the skin against deterioration linked to a stress-induced dysfunction of the apoptotic and immune defence processes
US8586541B2 (en) * 2006-06-01 2013-11-19 Therapeutic Peptides, Inc. Polymeric biosurfactants
US8987212B2 (en) 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
US20090162306A1 (en) * 2007-12-21 2009-06-25 Conopco, Inc., D/B/A Unilever Topical composition comprising coloring antioxidants
JP6205104B2 (ja) * 2010-04-30 2017-09-27 三井製糖株式会社 抗老化剤
FR2986233B1 (fr) 2012-02-01 2014-02-28 Regentis Internat Peptide bifonctionnel
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
EP3099308A4 (de) * 2014-01-29 2017-08-02 Pour Moi Beauty, LLC Hautpflegesystem
US9464926B2 (en) 2014-09-23 2016-10-11 Micro Motion, Inc. Magnetic flowmeter flowtube assembly with spring-energized seal rings
EP3253400B1 (de) 2015-02-05 2023-01-18 Muhammed Majeed Oleanoylpeptidzusammensetzung
CN108042414B (zh) * 2017-11-30 2020-11-17 宁国市永鼎知识产权运营有限公司 一种润发发膜
CN113755500B (zh) * 2020-05-18 2023-04-07 湖南杂交水稻研究中心 水稻氨基酸转运子OsAAP7基因及其应用
US12246080B2 (en) 2022-01-31 2025-03-11 L'oreal High active content cosmetic serum composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
FR2672288B1 (fr) * 1991-02-06 1993-04-23 Oreal Nouveaux amides dipeptidiques derivant de la glycyl-serine, utilisables, notamment dans des compositions cosmetiques, pharmaceutiques ou alimentaires.
WO1998036742A1 (en) * 1997-02-25 1998-08-27 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
FR2782638B1 (fr) * 1998-08-28 2003-04-11 Shiseido Internat France S A S Utilisation en cosmetique d'acides gras
US6552223B1 (en) * 1998-08-31 2003-04-22 Astrazeneca Ab N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them
FR2782919B1 (fr) * 1998-09-04 2001-05-25 Roc Sa Composition contre le vieillissement et son utilisation
JP2000178163A (ja) * 1998-12-11 2000-06-27 Kao Corp 皮膚外用剤
FR2799370B1 (fr) * 1999-10-07 2005-08-19 Oreal Utilisation du lycopene dans des compositions destinees a traiter les signes cutanes du vieillissement
FR2810033B1 (fr) * 2000-06-08 2004-04-30 Oreal Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
FR2826267B1 (fr) 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent myorelaxant
FR2826265B1 (fr) 2001-06-26 2005-02-18 Oreal Composition cosmetique ou dermatologique comprenant une association entre un inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent antifongique et/ou antibacterien
FR2826263B1 (fr) 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un compose anti-inflammatoire

Also Published As

Publication number Publication date
US6884425B2 (en) 2005-04-26
JP2003048809A (ja) 2003-02-21
JP2006022114A (ja) 2006-01-26
FR2826266A1 (fr) 2002-12-27
DE60220594D1 (de) 2007-07-26
CA2391585A1 (fr) 2002-12-26
US20030044438A1 (en) 2003-03-06
ES2286215T3 (es) 2007-12-01
US20050142081A1 (en) 2005-06-30
JP4086867B2 (ja) 2008-05-14
US7838020B2 (en) 2010-11-23
EP1275372A1 (de) 2003-01-15
FR2826266B1 (fr) 2005-02-25
EP1275372B1 (de) 2007-06-13
DE60220594T2 (de) 2008-02-07

Similar Documents

Publication Publication Date Title
ATE364370T1 (de) Kosmetische und dermatologische zusammensetzung enthaltend ein n-acylaminoamid-derivat und einen metalloproteinase-inhibitor
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
WO2004018431A3 (en) Novel phenanthridines
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
NO20040198L (no) Dolastatin 10 derivater
DK1373259T3 (da) Pyridazinonaldosereduktaseinhibitorer
HUP0400327A3 (en) Azole derivatives having metalloproteinase inhibitor effect pharmaceutical compositions containing them and their use
BR0317715A (pt) Composições e processos de uso de collajolie
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
DK1560584T3 (da) Fab I inhibitorer
DE60219068D1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
FR2848116B1 (fr) Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
ZA923602B (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
DE60201627D1 (de) Fluorelastomerzusammensetzungen
DE60105418D1 (de) Serinprotease-inhibitoren
FR2826263B1 (fr) Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un compose anti-inflammatoire
DE60305522D1 (de) Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer
DE60202669D1 (de) 6-phenylbenzonaphthyidine
ATE357274T1 (de) Kosmetische und dermatologische zusammensetzung enthaltend n-acylaminoamid-derivate
EA200301101A1 (ru) Производные пиперазина и их применение в качестве ингибиторов pde4
ATE385775T1 (de) Kosmetische zusammensetzungen
DE60236685D1 (de) Schraubenkompressor mit verringerter leckage
DE602004009313D1 (de) Organosiliziumverbindungen und deren verwendung
WO2002057248A3 (en) Inhibitors of cruzipain and other cysteine proteases
DE60313331D1 (de) Neue benzonaphthyridine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties